Cosmo Pharmaceuticals NV
SIX:COPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
IE |
|
O
|
Origin Property PCL
SET:ORI
|
TH |
|
FirstRand Ltd
OTC:FANDY
|
ZA |
|
Theratechnologies Inc
TSX:TH
|
CA |
|
Chocoladefabriken Lindt & Spruengli AG
F:LSPN
|
CH |
|
T
|
Thales SA
DUS:CSF
|
FR |
|
S
|
Societe BIC SA
OTC:BICEF
|
FR |
|
K
|
Koninklijke Philips NV
SWB:PHI1
|
NL |
|
A
|
Asics Corp
OTC:ASCCF
|
JP |
|
Italian Wine Brands S.P.A.
MIL:IWB
|
IT |
|
C
|
Comba Telecom Systems Holdings Ltd
OTC:COBJF
|
HK |
|
E
|
Euroapi SAS
PAR:EAPI
|
FR |
|
Constellation Energy Corp
NASDAQ:CEG
|
US |
|
A
|
Andean Precious Metals Corp
XTSX:APM
|
CA |
|
Majestic Corporation PLC
OTC:MCJCF
|
UK |
|
L
|
Lenzing AG
DUS:LEN
|
AT |
|
W
|
Workpoint Entertainment PCL
SET:WORK
|
TH |
|
Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA
F:E28
|
RO |
|
I
|
Imexpharm Corp
VN:IMP
|
VN |
|
KDDI Corp
F:DIP
|
JP |
|
B
|
BCE Inc
XMUN:BCE1
|
CA |
|
P
|
Panasonic Holdings Corp
F:MATA
|
JP |
|
P
|
Public Service Enterprise Group Inc
SWB:PSE
|
US |
|
M
|
MTN Group Ltd
JSE:MTN
|
ZA |
Dividends
Dividend Yield
Cosmo Pharmaceuticals NV
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Cosmo Pharmaceuticals NV
COPN have decreased by 0%.
Payout Ratio
Cosmo Pharmaceuticals NV
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for COPN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
COPN Price
Cosmo Pharmaceuticals NV
| Average Annual Return | -5.87% |
| Standard Deviation of Annual Returns | 17.08% |
| Max Drawdown | -62% |
| Market Capitalization | 1.2B CHF |
| Shares Outstanding | 17 540 000 |
| Percentage of Shares Shorted |
N/A
|
